REDUCEDT+30
Mainolfi Nello
Kymera Therapeutics Inc · NASDAQ
−8,230 sh · $949.7K
Filed 1 Oct 2026SEC Form 4view source
Mainolfi Nello
Kymera Therapeutics Inc · NASDAQ
−8,230 sh · $949.7K
Mainolfi Nello
Kymera Therapeutics Inc · NASDAQ
−262 sh · $30.4K
Mainolfi Nello
Kymera Therapeutics Inc · NASDAQ
−7,601 sh · $869.8K
Mainolfi Nello
Kymera Therapeutics Inc · NASDAQ
−5,506 sh · $619.0K
Mainolfi Nello
Kymera Therapeutics Inc · NASDAQ
−3,525 sh · $392.8K
Mainolfi Nello
Kymera Therapeutics Inc · NASDAQ
+30,000 sh · $62.4K
Mainolfi Nello
Kymera Therapeutics Inc · NASDAQ
−4,876 sh · $552.2K
Adams Brian
Kymera Therapeutics Inc · NASDAQ
−2,137 sh · $251.2K
Adams Brian
Kymera Therapeutics Inc · NASDAQ
−3,025 sh · $353.4K
Adams Brian
Kymera Therapeutics Inc · NASDAQ
−1,209 sh · $139.7K